alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
xml version="1.0" encoding="UTF-8"?


C\_2018414EN.01001401.xml


| | | | |
| --- | --- | --- | --- |
| 15.11.2018 | EN | Official Journal of the European Union | C 414/14 |

---

Prior notification of a concentration

(Case M.9156 — CMI / Hachette Filipacchi / Lagardère Publicité / Lagardère Digital France)

Candidate case for simplified procedure

(Text with EEA relevance)

(2018/C 414/16)

1.

On 8 November 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2018414EN.01001401-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | Czech Media Invest (‘CMI’, Czech Republic), |

| | |
| --- | --- |
| — | Hachette Filipacchi Associés, Lagardère Publicité, and Lagardère Digital France (France), belonging to the Lagardère Group. |

CMI acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Hachette Filipacchi Associés, Lagardère Publicité, and Lagardère Digital.

The concentration is accomplished by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

—   for CMI: (i) the publishing of press titles and their related editorial websites, radio broadcasting; and (ii) the sale of advertising spaces in such media,

—   for Hachette Filipacchi Associés, Lagardère Publicité, and Lagardère Digital France: (i) publishing of magazines titles and their related editorial websites; and (ii) the sale of advertising spaces in such media.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2018414EN.01001401-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9156 — CMI / Hachette Filipacchi / Lagardère Publicité / Lagardère Digital France

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

| |
| --- |
| Email: COMP-MERGER-REGISTRY@ec.europa.eu |
| Fax +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2018414EN.01001401-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2018414EN.01001401-E0002)  [OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4797 Introduced in House (IH)]

110th CONGRESS
  1st Session
                                H. R. 4797

    To extend the suspension of duty on mixtures of cyhalothrin and 
                         application adjuvants.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           December 18, 2007

  Mr. Coble introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
    To extend the suspension of duty on mixtures of cyhalothrin and 
                         application adjuvants.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MIXTURES OF CYHALOTHRIN AND APPLICATION ADJUVANTS.

    (a) In General.--Heading 9902.02.09 of the Harmonized Tariff 
Schedule of the United States (relating to mixtures of cyhalothrin and 
application adjuvants) is amended by striking ``12/31/2009'' and by 
inserting ``12/31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
UN PUBLISHED
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 19
- 1580

KINGGOBE AFRICAN ASSEGAI, VII , Plaintiff

- Appellant ,

v. ANDREW SAUL, Commissioner of Social Security Administration; ATTORNEY GENERAL OF THE UNITED STATES , Defendants

- Appellees

.

Appeal from the United States District Court for the Eastern District of Virginia , at Richmond

. Henry E. Hudson, Senior District Judge. ( 3:18

- cv
- 00490

- HEH )

Submitted : September 27, 2019 Decided: October 8, 2019

Before KING , FLOYD, and QUATTLEBAUM, Circuit Judges.

Affirmed by un published per curiam opinion

.
Kinggobe African Assegai, VII , Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM:
Ki nggobe African Assegai, VII, appeals the district court’s order accepting the recommendation of the magistrate judge and upholding the Administrative Law Judge’s denial of Assegai’s claim for additional retirement benefits . We have reviewed the record
and find no reversible error. Accordingly, we affirm the district court ’s order

. Assegai v.
Saul , No. 3:18

- cv
- 00490

- HEH (E.D. Va. May 14, 2019) . We dispense with oral argument because the facts and legal contentions are adequately presented in the material s before this court and argument would not aid the decisional process.
AFFIRMED
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4966 Introduced in House (IH)]

110th CONGRESS
  2d Session
                                H. R. 4966

       To extend the temporary suspension of duty on Isobutyl 4-
                  hydroxybenzoate and its sodium salt.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 15, 2008

 Mrs. Myrick introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
       To extend the temporary suspension of duty on Isobutyl 4-
                  hydroxybenzoate and its sodium salt.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ISOBUTYL 4-HYDROXYBENZOATE AND ITS SODIUM SALT.

    (a) In General.--Heading 9902.22.41 of the Harmonized Tariff 
Schedule of the United States (relating to Isobutyl 4-hydroxybenzoate 
and its sodium salt) is amended by striking ``12/31/2009'' and 
inserting ``12/31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
I 

113TH CONGRESS 

1ST SESSION H. R. 1523 

To amend the Controlled Substances Act to provide for a new rule regarding 

the application of the Act to marihuana, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 12, 2013 

Mr. ROHRABACHER (for himself, Mr. COHEN, Mr. YOUNG of Alaska, Mr. 

POLIS, Mr. AMASH, and Mr. BLUMENAUER) introduced the following bill; 

which was referred to the Committee on the Judiciary, and in addition 

to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such 

provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To amend the Controlled Substances Act to provide for a 

new rule regarding the application of the Act to marihuana, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Respect State Mari5 juana Laws Act of 2013’’. 


tkelley on DSK3SPTVN1PROD with BILLS
2 

•HR 1523 IH

1 SEC. 2. RULE REGARDING APPLICATION TO MARIHUANA. 

2 Part G of the Controlled Substances Act (21 U.S.C. 

3 801 et seq.) is amended by adding at the end the fol4 lowing: 

5 ‘‘SEC. 710. RULE REGARDING APPLICATION TO MARI6 HUANA. 

7 ‘‘Notwithstanding any other provision of law, the pro8 visions of this subchapter related to marihuana shall not 

9 apply to any person acting in compliance with State laws 

10 relating to the production, possession, distribution, dis11 pensation, administration, or delivery of marihuana.’’. 

Æ 


tkelley on DSK3SPTVN1PROD with BILLS
IMES v. ASHEVILLE.

No. 250A04.

Supreme Court of North Carolina.

July 1, 2004.

April Burt Sutton, for James Edward Imes.

Fred T. Hamlet, Greensboro, for CCL Mgt. and Asheville City Coach.

Curtis W. Euler, for City of Asheville.

Andrea S. Kurtz, for Legal Momentum.

The following order has been entered on the motion filed on the 7th day of June 2004 by Legal Momentum, et al for Leave to File Amicus Curiae Brief:

> "Motion Allowed by order of the Court in conference this the 1st day of July 2004."
I 

110TH CONGRESS 

1ST SESSION H. R. 4870 

To suspend temporarily the duty on Basic Red 51. 

IN THE HOUSE OF REPRESENTATIVES 

DECEMBER 19, 2007 

Mr. CLAY introduced the following bill; which was referred to the Committee 

on Ways and Means 

A BILL 

To suspend temporarily the duty on Basic Red 51. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. BASIC RED 51. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.l.l Basic Red 51 (CAS No. 

12270–25–6) (provided for 

in subheading 3204.13.80) .. Free No change No change On or before 

12/31/2011 ’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies to articles entered, or withdrawn 


bajohnson on PROD1PC69 with BILLS
2 

•HR 4870 IH

1 from warehouse for consumption, on or after the 15th day 

2 after the date of the enactment of this Act. 

Æ 


bajohnson on PROD1PC69 with BILLS
**Exhibit10.3**

 

 

August3, 2006

StephenC. Costalas, Esq.
| Re: |   | Amendment to Severance Agreement dated December 2,  2004 and amended November 3, 2005   between Pharmacopeia Drug Discovery, Inc. (“Pharmacopeia”) and Stephen C.  Costalas   (the “Agreement”) |
|-----|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

Dear Mr. Costalas:

Referenceis made to the Agreement.

Inconsideration of your continued employment by Pharmacopeia, Pharmacopeia andyou hereby agree to amend and restate Section 3(a) (Taxes—General) of theAgreement in its entirety as follows:

Section 3(a)

“**3.  TAXES.** (a)  General.  Employee will be responsible for the paymentof any tax liability incurred as a result of this Agreement.  The Company may withhold tax on any paymentsor benefits provided to Employee as required by law or regulation.  Notwithstanding anything herein to thecontrary, if any payments due under this Agreement would subject the Employeeto any tax imposed under Section 409A of the Internal Revenue Code of1986, as amended (the “Code”) if such payments were made at the time otherwiseprovided herein, then the payments that cause such taxation shall be payable ina single lump sum on the first day which is at least six months after the dateof the Employee’s “separation of service” as set forth in Code Section 409Aand the regulations issued thereunder.”

[Theremainder of this page intentionally left blank.]

----

 

Ifyou are in agreement with the terms of this letter agreement please sign belowand return one copy to my attention.
| Very  truly yours,                    |
|---------------------------------------|
|                                  |
| /s/ Leslie J. Browne, Ph.D.           |
|                                  |
| Leslie J. Browne, Ph.D.               |
| President and Chief Executive Officer |
|                                  |
|                                  |
| ACKNOWLEDGED, AGREED AND              |
| ACCEPTED THIS 3RD DAY OF              |
| AUGUST, 2006                          |
|                                  |
|                                  |
| /s/ Stephen C. Costalas               |   |
| Stephen C. Costalas                   |
| Executive Vice President and          |
| General Counsel                       |

 

----
Farid POPAL, Petitioner, v. Stephen BROWN.

No. 19-7866.

Supreme Court of the United States.

May 18, 2020

Motion of petitioner for leave to proceed *in forma pauperis* denied, and petition for writ of certiorari to the United States Court of Appeals for the Second Circuit dismissed. See Rule 39.8.
**Exhibit 3.8**

 

**THIRD CERTIFICATE OF AMENDMENT**

**OF**

**RESTATED CERTIFICATE OF INCORPORATION**

**OF**

**VIISAGE TECHNOLOGY, INC.**

 

Viisage Technology, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of theState of Delaware (the “Corporation”), DOES HEREBY CERTIFY: 

 

FIRST: That the Board of Directors of the Corporation, by vote pursuant to a consent in lieu of meeting of its members as filed with the minutes of the board, duly adopted resolutions setting forth a proposed third amendment to the RestatedCertificate of Incorporation, declaring said amendment to be advisable to the stockholders of the Corporation. The resolution setting forth the proposed amendment is as follows: 

 

“RESOLVED, that the Restated Certificate of Incorporation of this corporation be further amended by changing Section 1of Article Fourth thereof so that, as amended, said Article shall be and read as follows: 

 

Section 1. Number of shares: 

 

The total number of shares of capital stock which the Corporation shall have authority to issue is Seventy-Seven Million (77,000,000) shares, of which (a) Seventy-Five Million (75,000,000) shall be Common Stock, par value $0.001 per share(the “Common Stock”), and (b) Two Million (2,000,000) shall be Preferred Stock, par value $0.001 per share (the “Preferred Stock”). As set forth in this Article IV, the Board of Directors of the Corporation (the “Board ofDirectors”) is authorized from time to time to establish and designate one or more series of Preferred Stock, to fix and determine the variations in the relative rights and preferences as between the different series of Preferred Stock in themanner hereinafter set forth in this Article IV, and to fix or alter the number of shares comprising any such series and the designation thereof to the extent permitted by law. 

 

Any and all such shares issued, and for which the full consideration has been paid or delivered, shall be deemed fully paidstock and the holder of such shares shall not be liable for any further call or assessment or any other payment thereon. 

 

The Board of Directors is authorized to issue, from time to time, all or any portion of the capital stock of the Corporation, of any class, which may havebeen authorized but not issued or otherwise reserved for issue, to such person or persons and for such lawful consideration (including property or services at their fair value), as it may deem appropriate, and generally in its absolute discretion todetermine the terms and manner of any disposition of such authorized but unissued capital stock.” 

 

SECOND: That said amendment was duly adopted by the shareholders of the Corporation in accordance with the provisions of Section 242 of the GeneralCorporation Law of the State of Delaware. 

 

IN WITNESS WHEREOF,said Viisage Technology, Inc. has caused this certificate to be signed by Charles J. Johnson, Esq., its Secretary, this 14th day of June, 2004.
Exhibit
32.1
 
 CERTIFICATION
PURSUANT TO
 18 U.S.C.
ss.1350, AS ADOPTED PURSUANT TO
 SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
 
 In connection with the Annual Report of
Integral Technologies, Inc. (the “:Company”) on Form 10-K for the fiscal year
ended June 30, 2009 as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), I, William S. Robinson, Chief Executive Officer of
the Company, certify, pursuant to 18 U.S.C. section 906 of the Sarbanes-Oxley
Act of 2002, that:
 
 (1)           The
Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
 (2)           The
information contained in the Report fairly presents, in all material respects,
the financial condition and result of operations of the Company.
 
 A signed
original of this written statement required by Section 906 has been provided to
the Company and will be retained by the Company and furnished to the Securities
and Exchange Commission or its staff upon request.
 
 
 September
28, 2009
 
 
 /s/ William S. RobinsonWilliam
      S. Robinson, Chief Executive Officer
EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and in connection with the Quarterly Report on Form 10-Q of Paladin Realty Income Properties, Inc. (the Company) for the period ended September 30, 2010, as filed with the Securities and Exchange
Commission on the date hereof (the Report), the undersigned, the Executive Vice President, Chief Financial Officer and Director of the Company, certifies, to his knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.



|                                                              
|--------------------------------------------------------------
|/s/ John A. Gerson                                            
|John A. Gerson                                                
|Executive Vice President, Chief Financial Officer and Director
|(Principal Financial and Accounting Officer)                  

November 15, 2010
EXHIBIT 32.1





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO SECTION 906


OF THE SARBANES-OXLEY ACT OF 2002





The undersigned, John M. Sharpe, Jr., the Chief Executive Officer, Chairman of the Board of Directors and Treasurer of INNER SYSTEMS, INC. (the “Company”), DOES HEREBY CERTIFY that:





1.  The Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2011 (the “Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and





2.  Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.





IN WITNESS WHEREOF, each of the undersigned has executed this statement this 15th day of August, 2011.





/s/ John M. Sharpe, Jr.John M. Sharpe, Jr.Chief Executive Officer and Chief Financial Officer





A signed original of this written statement required by Section 906 has been provided to INNER SYSTEMS, INC. and will be retained by INNER SYSTEMS, INC. and furnished to the Securities and Exchange Commission or its staff upon request.
Jason ALSTON, Petitioner v. Arianna W. EASTMAN.

No. 19-5823

Supreme Court of the United States.

November 4, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
1

The Honorable Charles R. Wolle, United States District Judge for the Southern

District of Iowa.

United States Court of Appeals

FOR THE EIGHTH CIRCUIT

___________

No. 02-1960

___________

United States of America, *

*

Appellee, *

*

v. * Appeal from the United States

* District Court for the Southern

Jennifer Regenos, * District of Iowa.

* [UNPUBLISHED]

Appellant. *

___________

 Submitted: December 20, 2002

 Filed: December 27, 2002 

___________

Before WOLLMAN, FAGG, and MELLOY, Circuit Judges.

___________

PER CURIAM.

Jennifer Regenos pleaded guilty to conspiring to distribute and possess with

intent to distribute more than 50 grams of methamphetamine and more than 500

grams of a substance containing methamphetamine, in violation of 21 U.S.C.

§§ 841(a)(1), 841(b)(1)(A), and 846. The district court1

 sentenced her to 240 months

of imprisonment and 10 years of supervised release, as that was the statutory

minimum sentence given her prior felony drug conviction. On appeal, counsel has
-2-

moved to withdraw and filed a brief under Anders v. California, 386 U.S. 738 (1967),

arguing that the sentence amounts to cruel and unusual punishment under the Eighth

Amendment.

This argument is unavailing. Section 841 and its mandatory minimum

sentencing provisions have consistently withstood constitutional scrutiny. See, e.g.,

United States v. Mendoza, 121 F.3d 441, 442-43 (8th Cir. 1997) (20-year mandatory

minimum sentence for distribution of 1 pound of methamphetamine after prior drug

conviction was constitutional); United States v. Prior, 107 F.3d 654, 659-60 (8th Cir.)

(life sentence without parole for possessing with intent to distribute 1,147.6 grams of

methamphetamine after 3 prior drug convictions did not violate Eighth Amendment),

cert. denied, 522 U.S. 824 (1997); see also Harmelin v. Michigan, 501 U.S. 957,

1001-02 (1991) (Kennedy, J., concurring in part and concurring in the judgment)

(Eighth Amendment forbids only sentences grossly disproportionate to crime; life

sentence without parole for first offense of possession of less than 1 kilogram of

cocaine was not cruel and unusual punishment).

Following our independent review, see Penson v. Ohio, 488 U.S. 75 (1988), we

find no nonfrivolous issues. Accordingly, the judgment is affirmed. We also grant

counsel’s motion to withdraw.

A true copy.

Attest:

CLERK, U.S. COURT OF APPEALS, EIGHTH CIRCUIT.
Exhibit 32.2CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002     I, Erin E. West, Chief Financial Officer and Treasurer of ProCentury Corporation (the“Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:(1) the quarterly report on Form 10-Q of the Company for the period ended March 31, 2007which this certification accompanies fully complies with the requirements of Section 13(a)or 15(d) of the Securities Exchange Act of 1934; and (2) the information contained in the quarterly report fairly presents, in all materialrespects, the financial condition and results of operations of the Company.   /s/ Erin E. West   Erin E. West  Chief Financial Officer and Treasurer  May 8, 2007  
37
EDMONDS v. FRESENIUS MEDICAL CARE.

No. 487A04.

Supreme Court of North Carolina.

October 12, 2004.

Shannon P. Herndon, Charlotte, for Fresenius Medical Care.

*467Randy D. Duncan, for Edmonds.

The following order has been entered on the motion filed on the 12th day of October 2004 by Defendant for Extension of Time to File Brief:

> "Motion Allowed. Defendant (Fresenius Medical Care) shall have up to and including the 17th day of November 2004 to file and serve his/her brief with this Court. By order of the Court in conference this the 12th day of October 2004."
No. 85-55.

#### Bowen, Secretary of Health and Human Services *v.*Polaski et al.

C. A. 8th Cir. Certiorari granted, judgment vacated, and case remanded for further consideration in light of *Bowen*v. *City of New York, ante,*p. 467.
Michael BONIN, Petitioner v. UNITED STATES

No. 19-809

Supreme Court of the United States.

January 27, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Seventh Circuit denied.